Bio-Techne’s Bristol facility manufactures small molecules used by cell-therapy developers under Good Manufacturing Practice (GMP) standards.[1]
Bio-Techne announced on 8 October 2026 that the new facility was fully operational and producing GMP-grade small molecules.
The pin represents the Tocris/Bio-Techne Avonmouth postcode area, BS11 9QD. The new cleanroom building has not been pinpointed. [2][3]
Bio-Techne announced the opening of its fully operational Bristol GMP small-molecule manufacturing facility on 8 October. The purpose-built 10,000 sq ft facility has five ISO-8 and two ISO-7 cleanrooms and is manufacturing materials for cell-therapy developers.